Global InVitro Diagnostics Market - 2019-2026
|體外診斷 (IVD)的全球市場 Global InVitro Diagnostics Market - 2019-2026|
|出版日期: 2019年11月01日||內容資訊: 英文||
本報告提供全球體外診斷 (IVD) 市場相關調查分析，提供產業分析，市場分析，各地區分析，競爭情形，主要企業等相關的系統性資訊。
The Global In-Vitro Diagnostics Market was valued at USD xx million in 2018 and is estimated to reach USD xx million by 2025, with a CAGR of xx% during the forecast period (2019-2026).
The market is driven by several factors such as growing usage of POC diagnostics, increasing aging population and rapid occurrence of infectious diseases, but the market is also affected by the stringent regulations from the different regulatory bodies across the globe.
The growth of in-vitro diagnostics market is also hindered by the limited budget of hospitals and laboratories in the developing nations.
Some of the infectious disease, such as influenza testing, have well-established POCTs with approx.78% of flu testing performed at physician level in the US.
There is a huge competition in POC market segment which is leading to pricing pressure in the absence of meaningful developments in product differentiation.
Certain concerns over specificity and sensitivity of rapid tests are pushing towards the development of molecular assays, however these come at a significantly higher cost (>US$ 100 per patient, versus c. US$ 15 per patient for the rapid POCTs), which is likely to limit the volume growth of these tests outside of narrow patient populations (e.g. immuno-compromised) if consumable cost alone is accounted for.
The global In-Vitro Diagnostics market is segmented by a technique such as Immunochemistry Bacterial Toxicity Assays, POC diagnostics, Molecular Diagnostics, Hematology, Tissue Diagnostics, Microbiology, Self- blood glucose monitoring, and Others.
Based on Product type, the market is segmented into Instruments, Reagents, and Data Management Systems.
Further, the market is segmented by applications into Infectious Diseases, Diabetes, Cancer/Oncology, Cardiology, Autoimmune Diseases, Nephrology, Drug Testing, HIV/AIDS, and Others. By end-user, the market is segmented into Laboratories, Hospitals, Academics, and Others.
Geographically, the market is segmented into North America, South America, Europe, Asia Pacific and RoW.
The report covers the factors impacting the market, Porter 5 Forces, Market Share Analysis, Price trend analysis, Product Benchmarking, and company profiles.
The major companies in the In-Vitro Diagnostics market include BioMerieux, Danaher Corporation, Roche Diagnostics, Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Abbott Laboratories, Bayer AG, Arkray Inc., Sysmex Corporation, Johnson & Johnson, and Siemens AG.
Visualize the composition of the In-Vitro Diagnostics in the market across each indication, in terms of type and applications, highlighting the key commercial assets and players.
Identify commercial opportunities in In-Vitro Diagnostics by analyzing trends and co-development deals.
Excel data sheet with thousands of data points of the In-Vitro Diagnostics market level 4/5 segmentation
PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study
Product mapping in excel for the key In-Vitro Diagnostics products of all major market players